Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content
Fig. 7 | Cell Communication and Signaling

Fig. 7

From: VSIG2 promotes malignant progression of pancreatic ductal adenocarcinoma by enhancing LAMTOR2-mediated mTOR activation

Fig. 7

Overexpression of VSIG2 was associated with poor prognosis of PDAC patients. A Western blotting was performed on 12 pairs of pancreatic and para-cancerous tissues collected from PDAC patients, when GAPDH was served as a loading control. B 3 pairs of tumor and para-tumor tissues collected from PDAC patients were compared by immunohistochemistry (IHC) assay. C Scatter diagram of staining index about 12 pairs PDAC and adjacent tissue samples using 12-tier IHC scoring. D Overall survival curve was drawn through observing and recording the condition of PDAC patients for 43 months, while all PDAC patients were divided into two groups by VSIG2 expression level. E Disease-free survival probability of PDAC patients with different expression level of VSIG2 was acquired by Kaplan-Meier (https://kmplot.com/analysis/) database. F Forest plot of univariate Cox analysis regarding to multiple parameters. G Forest plot of multivariate Cox analysis regarding to multiple parameters

Back to article page